News | Mammography | July 11, 2017

Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017

Package offers access to the latest versions of VolparaDensity, VolparaDose and VolparaPressure software tools in a subscription model

Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017

July 11, 2017 — Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging Management (AHRA)'s 45th Annual Meeting and Exposition, July 9-12, in Anaheim, Calif. The VolparaEnterprise Clinical Applications software package offers access to VolparaDensity, VolparaDose and VolparaPressure, in a software-as-a-service (SaaS) subscription model for the first time. Volpara Solutions will showcase its entire suite of quantitative breast imaging tools, which allow for personalized measurements of volumetric breast density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.

VolparaEnterprise Clinical Applications provide quick, automated assessment of every mammography and tomosynthesis exam and produces a Volpara Scorecard for every patient with the following data:

  • VolparaDensity helps radiologists assess breast density more objectively and helps them better consider who might benefit from additional screening. The volumetric Volpara Density Grades have been shown to correlate strongly to the sensitivity of mammography and have demonstrated a strong association with the risk of developing breast cancer;
  • VolparaDose helps understand the X-ray dose delivered to the patient, based on her specific breast density. Unlike manufacturer dose, which is based on phantom measurements, VolparaDose is computed based on the patient's breast composition and provides a personalized dose measure because no two women are alike; and
  • VolparaPressure helps evaluate the effectiveness of the mammogram and better understand the patient experience. The lack of consistent guidelines regarding mammographic compression has led to wide variation in its technical execution, as well as varying levels of discomfort or pain. VolparaPressure helps monitor and optimize pressure during mammography exams, which is important to decrease the discomfort experienced by women and to optimize screening outcomes.

VolparaEnterprise software, a Microsoft Azure-based solution, delivers key performance indicators (KPIs) for hundreds of performance and quality metrics, including patient positioning, compression and equipment utilization. The software provides continuous quality assurance and performance monitoring through dynamic, interactive dashboards. Updated with every mammography or tomosynthesis (3-D mammography) exam, ConstantQuality metrics may help facilities comply with the U.S. Food and Drug Administration’s (FDA's) new Enhancing Quality Using the Inspection Program (EQUIP). 

Designed to support large or small enterprises, VolparaEnterprise software enables breast centers to perform rapid quality control checks that help optimize the productivity and efficiency of imaging resources. This in turn helps decrease costs through the reduction of retakes, increase employee effectiveness, and enhance the patient experience.

For more information: www.volparasolutions.com

Related Content

Konica Minolta Dynamic Digital Radiography Receives FDA Clearance

With DDR, orthopedists and MSK specialists can acquire a full view of the MSK system in the supine and prone positions to view changes in the bone and articulations throughout the full range of motion. Image courtesy of Konica Minolta Healthcare Americas.

Technology | Digital Radiography (DR) | April 23, 2019
Konica Minolta Healthcare Americas Inc. announced that its Dynamic Digital Radiography (DDR) technology, introduced at...
GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...